Celine Muller
Reims, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept study.
Journal: The British journal of dermatology
Published: April 18, 2025
Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity.
Journal: The British journal of dermatology
Published: October 17, 2023
Neutrophil Extracellular Traps Generation Relates with Early Stage and Vascular Complications in Systemic Sclerosis.
Journal: Journal of clinical medicine
Published: June 06, 2020
Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid.
Journal: Frontiers in immunology
Published: June 25, 2019
IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid.
Journal: Frontiers in immunology
Published: June 12, 2019
Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid.
Journal: Frontiers in immunology
Published: May 27, 2019
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.
Journal: Frontiers in immunology
Published: January 04, 2019
Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
Journal: Experimental dermatology
Published: September 07, 2018
Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.
Journal: Frontiers in immunology
Published: January 12, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026